Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company primarily serves doctors, hospitals, and medical centers in the field of psychiatry. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.

BrainsWay Ltd.

Flow Neuroscience develops a non-invasive brain stimulation technology called tDCS for the treatment of depression.

Flow Neuroscience

BrainsWay is a global medical technology company that develops advanced medical devices for mental healthcare, focusing on Deep Transcranial Magnetic Stimulation (Deep TMS) for the treatment of mental health disorders.

Metric
Company Name	BrainsWay Ltd.	Flow Neuroscience
Symbol	BWAY
MSH ID	COM:BRAINSWAY	COM:FLOWNEUROSCIENCE
Market	STOCKS	PRIVATE
Sector	Healthcare	Healthcare & Health Services
Industry	Medical - Devices	Mental Health Services
Country	IL	GB
Stage
Employee Count	134
Website	brainsway.com	flowneuroscience.com
LinkedIn
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic		77.08K
Web Traffic Growth		-0.37
Valuation
Raised Capital

Metric
Revenue	31.79M
Revenue (LTM)
Revenue (NTM)
Gross Profit	23.48M
EBITDA	-2.50M
Operating Income	4.96M
Net Income	-4.20M
EPS	-0.13
Diluted EPS	-0.13
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.75
Operating Profit Margin	0.29
EBITDA Margin	-0.08
Net Profit Margin	0.02
Return on Equity	0.01
Return on Assets	0.01
Return on Capital Employed	0.20

COM:BRAINSWAY

BrainsWay

Last Close

1,817.00

25/11 09:19

Market Cap

381.35M

Beta: -

Volume Today

9.59K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	-11.70
P/B Ratio	2.32
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	4.56
EV Multiple	78.67

Metric
Days Sales Outstanding	43.33
Days Payables Outstanding	23.23
Days Inventory Outstanding	165.09
Operating Cycle	208.43
Cash Conversion Cycle	185.20
Asset Turnover	0.56

Metric
Operating Cash Flow	1.28M
Free Cash Flow	-1.10M
Cash Flow to Debt	2.73
Operating Cash Flow/Sales	0.23
Free Cash Flow Yield	-0.05

Metric
Cash & Equivalents	10.52M
Accounts Receivable	1.09M
Inventory	3.72M
Goodwill
Debt to Capitalization	0.11
Debt to Assets	0.08
Current Ratio	6.36
Quick Ratio	5.76

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.02
R&D to Revenue	0.26
SG&A to Revenue	0.20